Using AI to improve safety in radiation therapy treatment planning
Development and Assessment of Artificial Intelligence (AI)-Enhanced Pre-treatment Peer-review Process to Improve Patient Safety in Radiation Oncology
This study is testing a new AI tool to help doctors in radiation therapy work together better and make fewer mistakes before starting treatment, all to keep patients safer and improve their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11062383 on NIH RePORTER |
What this research studies
This research aims to develop and implement an artificial intelligence (AI) and machine learning (ML) intervention to enhance the pre-treatment peer-review process in radiation oncology. By focusing on reducing physician variability, the project seeks to improve the performance of radiation therapy providers and ultimately enhance patient safety. The effectiveness of this intervention will be evaluated in real clinical settings, measuring the impact on treatment planning errors that can affect patient outcomes. The study will involve analyzing data from radiation therapy cases before and after the implementation of the AI-enhanced peer-review process.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing radiation therapy for cancer treatment.
Not a fit: Patients who are not receiving radiation therapy or those whose treatment plans are not subject to peer review may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce treatment planning errors in radiation therapy, leading to safer and more effective cancer treatment for patients.
How similar studies have performed: Other research has shown promising results using AI to enhance clinical processes, indicating that this approach has potential for success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Mazur, Lukasz — Univ of North Carolina Chapel Hill
- Study coordinator: Mazur, Lukasz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.